Pharmaceutical Executive Digest Europe - February 18, 2009 - (Page 12)

Pharma’s Facebook With the social media phenomenon one of the biggest success stories of the Web 2.0 era, Peter Houston explores how LinkedIn is helping pharma get in on the act. S ocial media is big news. From Facebook to Twitter, individuals are embracing the opportunity to participate in online publishing at an unprecedented rate. Communities of users interact globally, minute-to-minute within huge databases of content that they themselves create. The social media revolution has even spread to the pathologically cautious pharma market. According to Lisa Flaiz of digital agency Razorfish, several pharma companies are experimenting with branded Facebook pages and YouTube channels. But don’t get too excited. Pharmasponsored patient communities are a long way from being ubiquitous. The industry still can’t quite get its collective head around the removal of the ‘learned intermediary’ and is definitely not ready to turn the supply of drug information over to the patient community. So what is the pharma sector’s idea of good social media? If we leave marketing and patient education to one side, and assume that there’s no real value in a Texas Hold ‘Em tournament on Facebook, it leaves professional networking as the most exciting Web 2.0 activity for pharmaceutical execs. 1 7 NEWS VACCINES 2 11 FROM THE EDITOR / NEWS STRATEGY 5 CALENDAR 6 BRUSSELS REPORT 12 ONLINE NETWORKING 15 ON THE MOVE http://www.facebook.com/ http://twitter.com/PharmExecDigi http://www.razorfish.com/ http://pharmexec.findpharma.com/pharmexec/Web+Exclusives/The-Future-of-Media-and-Social-Influence-Marketing/ArticleStandard/Article/detail/579955?contextCategoryId=47505 http://www.youtube.com

Table of Contents Feed for the Digital Edition of Pharmaceutical Executive Digest Europe - February 18, 2009

Pharmaceutical Executive Digest Europe - February 18, 2009 Contents From the Editor News Calendar Brussels Report Vaccines Management Theory Online Networking On the Move

Pharmaceutical Executive Digest Europe - February 18, 2009

Pharmaceutical Executive Digest Europe - February 18, 2009 - Contents (Page 1) Pharmaceutical Executive Digest Europe - February 18, 2009 - From the Editor (Page 2) Pharmaceutical Executive Digest Europe - February 18, 2009 - News (Page 3) Pharmaceutical Executive Digest Europe - February 18, 2009 - News (Page 4) Pharmaceutical Executive Digest Europe - February 18, 2009 - Calendar (Page 5) Pharmaceutical Executive Digest Europe - February 18, 2009 - Brussels Report (Page 6) Pharmaceutical Executive Digest Europe - February 18, 2009 - Vaccines (Page 7) Pharmaceutical Executive Digest Europe - February 18, 2009 - Vaccines (Page 8) Pharmaceutical Executive Digest Europe - February 18, 2009 - Vaccines (Page 9) Pharmaceutical Executive Digest Europe - February 18, 2009 - Vaccines (Page 10) Pharmaceutical Executive Digest Europe - February 18, 2009 - Management Theory (Page 11) Pharmaceutical Executive Digest Europe - February 18, 2009 - Online Networking (Page 12) Pharmaceutical Executive Digest Europe - February 18, 2009 - Online Networking (Page 13) Pharmaceutical Executive Digest Europe - February 18, 2009 - Online Networking (Page 14) Pharmaceutical Executive Digest Europe - February 18, 2009 - On the Move (Page 15) http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091222http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091208http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091124http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091110http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091027http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20091013http://digital.findpharma.com/nxtbooks/advanstaruk/PEE_DIGEST_20090930http://digital.findpharma.com/nxtbooks/advanstaruk/PEE_digest_20090916http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090902http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090825http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090819http://digital.findpharma.com//nxtbooks/advanstaruk/pee_digest_20090812http://digital.findpharma.com//nxtbooks/advanstaruk/pee_digest_20090805http://digital.findpharma.com//nxtbooks/advanstaruk/pee_digest_20090729http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090721http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090715http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090708http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090701http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090624http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090617http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090610http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090602http://digital.findpharma.com/nxtbooks/advanstaruk/pee_digest_20090526http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090519http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090512http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090505http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_southafricahttp://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090429http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090422http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090415http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090408http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090401_v2http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090401http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090325http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090318http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090311http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090304http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090224http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090218http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090211http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090203http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090128http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090121http://www.nxtbook.com/nxtbooks/advanstaruk/pee_digest_20090114http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1008http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-ims1008http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0908http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0808http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0708http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0608http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-imssales0508http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0508http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0408http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0308http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0208http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-imssales0208http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0108http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-ims1207http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1107http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1007http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope-imsoncology0907http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0407http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope0307http://www.nxtbook.com/nxtbooks/advanstaruk/pharmexeceurope1206http://www.nxtbookMEDIA.com

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.